Chronic renal failure (CRF) is a set of pathologic processes, characterized by loss of renal function including reduction in glomerular filtration rate (GFR) and the formation of uremic syndrome (
1). End stage renal disease (ESRD) is the final stage of renal failure, with a GFR of < 15 mL/minute (
2). Globally, approximately 600 million people have CRF, with an annual mortality rate of 60,000 people (
3). The development and prevalence of ESRD in Iran is higher than that of the global rate, with an estimated prevalence rate of 1,200 to 1,600 per annum (
4,
5).
Although hemodialysis, as a substitute for the kidney, increases the survival and life expectancy in patients, it causes several problems such as psychological stress and social isolation of the patients (
6); therefore, increasing the longevity and quality-of-life should always be considered in the treatment of such patients (
7). Although patients with ESRD have been successfully treated with hemodialysis over the past four decades, the dialysis community is looking for a valid and simple criterion to evaluate the adequacy and effectiveness of treatment (
8). Kalender and Tosun believes that the adequacy of dialysis can reduce mortality, increase longevity, and improve the quality-of-life in patients undergoing hemodialysis (
9). On the other hand, poor and inadequate dialysis means higher disability and mortality rate (
10,
11). Effectiveness and adequacy of dialysis depend on many factors including type of filter, dialysis pump rate, dialysis time and speed, the application of high-flux dialyzer, blood flow rate, patient education, diet, and underlying diseases (
4,
10).
In general, urea reduction ratio (URR) and urea kinetic modeling (Kt/V) are used to evaluate the adequacy of dialysis (
12). The urea kinetic modeling represents a fractional volume cleared of urea per dialysis. The urea reduction ratio measures the difference in urea levels before and after the dialysis (
13). Achievement of a URR of about 65% (equivalent to a single pool Kt/V of 1.2) indicates an effective dialysis (
14). Data from different studies show that for every 0.1 increase in Kt/V, the mortality rate decreases by about 7%, and for every 5% increase in URR, the mortality rate decreases by 11% (
3). However, evidence from Iranian studies reported wide variation ranging from Kt/V index values of 0.58 to 1.6 (
15,
16) and URR index values of 47.84% to 69.83% (
17,
18).
Due to the importance of adequacy of dialysis in patients undergoing hemodialysis, evaluating the effectiveness and adequacy of dialysis in the current study would help policymakers and healthcare professionals to review and revise, if necessary, their current practice toward more effective dialysis. Various studies were conducted in different regions of Iran to evaluate the adequacy of dialysis in patients undergoing hemodialysis, but there is still no general estimate of the adequacy of dialysis in such patients in Iran. Moreover, the overall adequacy of dialysis in Iran is not clear in recent years.